AI-generated summary
The authors studied whether transcranial photobiomodulation at 808 nm or 1064 nm could improve behavior in 36 working dogs compared with an untreated control group, using four behavioral scales over 90 days. They report changes on some scales, with different wavelengths associated with different measures. The abstract describes this as a small, single-study behavioral evaluation without a stated certainty of effect.
- Participants
- 36
- Who or what was studied
- Working dogs (Belgian Malinois Shepherd, Dutch Shepherd and German Shepherd breeds), mean age 4.4 years, 24 males and 12 females, divided into a control group and two photobiomodulation groups.
- Wavelengths
- 808, 1064 nm
- Limits stated in the abstract
- The abstract reports a modest sample of 12 dogs per group, relies on behavioral questionnaires, and does not state whether outcomes were blinded or how the authors assessed the strength of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
To evaluate if transcranial photobiomodulation could improve behaviors in working dogs. PROCEDURES: Thirty-six animals were selected and divided into a no-intervention group (CG, n = 12) and two photobiomodulation groups (TG808 and TG1064, n = 12 for each). The Canine Frustration Questionnaire (CFQ), Dog Impulsivity Assessment Scale (DIAS), Lincoln Canine Adaptability Resilience Scale (L-CARS), and Positive and Negative Activation Scale (PANAS) were the selected outcome measures. They were collected on days 0, 8, 15, 30, 60, and 90 after the initial treatment. At each evaluation time point, group improvements were compared using the Kruskal-Wallis H test, followed by Dunn's post-hoc test, and the effect size was determined. A significance level of p < 0.05 was set.
Results
The animals in the sample had a mean age of 4.4 ± 2.0 years, with 24 males and 12 females. Three breeds were represented: Belgian Malinois Shepherd Dogs (n = 23), Dutch Shepherd Dog (n = 8), and German Shepherd Dogs (n = 5). Changes in the CFQ, L-CARS, and components were mainly driven by improvements in TG1064, with a large effect size. With the DIAS, changes were observed in TG808, with a large effect size. With the PANAS, changes were observed in both groups.
Conclusions And Clinical Relevance
This study showed that the described photobiomodulation protocols can improve behaviors in dogs, as evaluated with these behavioral scales. They can have a variety of applications, from behavioral medicine for wellbeing, to the management of hospital or clinical visits.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial photobiomodulation, Photobiomodulation therapy, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.